Kristen Ambrose, SVP & Chief Accounting Officer: Vertex Pharmaceuticals VRTX Sell · Filed 23/02/28

Trade details

Type: Insider sale
Amount: $282,079.5
Shares · price: 982 sh · $287.25 a share
Held after: 7,528 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Kristen AmbroseSVP & Chief Accounting Officer
Trade date: 23/02/27
Filed: 23/02/28
Days to filing: 1 days

Sold 11.5% of holdings

Share of holding sold: 11.5%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/28~23/03/29

Kristen Ambrose's recent trades

Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$172.6K
357 sh
$172.6K
Filed 03/02
Traded 02/26
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$108.5K
223 sh
$108.5K
Filed 02/26
Traded 02/25
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$762.1K
1,557 sh
$762.1K
Filed 02/19
Traded 02/17
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$302.2K
638 sh
$302.2K
Filed 02/19
Traded 02/18
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$633.6K
1,376 sh
$633.6K
Filed 02/12
Traded 02/11

Kristen Ambrose, CAO — sold $282.1K of Vertex Pharmaceuticals VRTX · 11.5% of holdings | Whalegun